In response to: Parodi MB, Iacono P, Zucchiatti I, et al. Choroidal Neovascularization Associated with Multiple Evanescent White Dot Syndrome Treated with Intravitreal Ranibizumab. (19th May 2018)

• Record Type: Journal Article
• Authors: Mathis, Thibaud; Kodjikian, Laurent
• Is Part Of: Ocular immunology and inflammation. Volume 26:Number 4(2018)
• Page Start: 612
• Page End: 613
• Publication Date: 2018-05-19
• Subjects: Eye -- Diseases -- Immunological aspects -- Periodicals; Eye -- Inflammation -- Periodicals; 617.7
• DOI: 10.1080/09273948.2017.1306086
• Languages: English
• ISSNs: 0927-3948

Abstract

Abstract: In response to the article by Parodi et al. about choroidal neovascularization (CNV) associated with Multiple Evanescent White Dot Syndrome (MEWDS) treated with intravitreal Ranibizumab. This article highlights the efficacy of intravitreal Ranibizumab in the treatment of CNV associated with MEWDS. In our experience, CNV is mostly associated with MEWDS in cases of a wider inflammatory spectrum such as overlapping syndrome with multifocal choroiditis (MFC) or punctuate inner choroidopathy (PIC). The whole pattern of the case presented in the article is compatible with the diagnosis of PIC, meaning that this case described an overlapping between MEWDS and PIC diagnoses. Although the authors wrote that CNV is secondary to MEWDS, another possible hypothesis is that CNV is secondary to PIC. Thus, MEWDS could be secondary to PIC and/or CNV.